Skip to main content
. 2011 Sep 9;12(9):5815–5827. doi: 10.3390/ijms12095815

Figure 1.

Figure 1

Influence of the SLCO1B1 *15 variant on reduction of total (TC) and low-density lipoprotein (LDL-C) cholesterol in response to atorvastatin (10 mg/day/4 weeks). P > 0.05, as compared by One-Way Analysis of Variance followed by Hom-Sidak test. Number of individuals in parenthesis.